Marcel Schmocker

Direktor/Vorstandsmitglied bei

BioXpress Therapeutics SA

Consumer Services

Commercial Services

Health Technology

Profil

Marcel Schmocker is currently a Director at BioXpress Therapeutics SA and IPRIS AG.
He was formerly a Director at Selexis SA. He received his graduate degree from Duke University in 1986 and his undergraduate degree from the University of Bern in 1983.

Aktive Positionen von Marcel Schmocker

Unternehmen	Position	Beginn
BioXpress Therapeutics SA BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity	Direktor/Vorstandsmitglied	-
IPRIS AG IPRIS AG Miscellaneous Commercial ServicesCommercial Services Provides intellectual property management services	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Marcel Schmocker

Ehemalige bekannte Positionen von Marcel Schmocker

Unternehmen	Position	Ende
Selexis SA Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines	Direktor/Vorstandsmitglied	-

Sehen Sie sich die Erfahrung von Marcel Schmocker im Detail an

Ausbildung von Marcel Schmocker

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Marcel Schmocker im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	5
Duke University Duke University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Bern University of Bern Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Selexis SA Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines	Commercial Services
BioXpress Therapeutics SA BioXpress Therapeutics SA BiotechnologyHealth Technology Provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity	Health Technology
IPRIS AG IPRIS AG Miscellaneous Commercial ServicesCommercial Services Provides intellectual property management services	Commercial Services